Cargando…
Cell-free DNA measurement of three genomes after allogeneic MSC therapy in kidney transplant recipients indicates early cell death of infused MSC
INTRODUCTION: Mesenchymal stromal cell (MSC) therapy is a promising treatment that allows for drug minimization in clinical kidney transplantation. While it is thought that MSCs rapidly go into apoptosis after infusion, clinical evidence for this is scarce since methods to detect cell death of infus...
Autores principales: | Dreyer, Geertje J., Drabbels, Jos JM., de Fijter, Johan W., van Kooten, Cees, Reinders, Marlies EJ., Heidt, Sebastiaan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652747/ https://www.ncbi.nlm.nih.gov/pubmed/38022634 http://dx.doi.org/10.3389/fimmu.2023.1240347 |
Ejemplares similares
-
Peripheral Blood Immune Cell Composition After Autologous MSC Infusion in Kidney Transplantation Recipients
por: Hendriks, Sanne H., et al.
Publicado: (2023) -
Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study
por: Reinders, Marlies E. J., et al.
Publicado: (2015) -
NK Cells and MSCs: Possible Implications for MSC Therapy in Renal Transplantation
por: Reinders, Marlies EJ, et al.
Publicado: (2014) -
Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients
por: Reinders, Marlies EJ, et al.
Publicado: (2014) -
Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients
por: Cheng, Rui-Juan, et al.
Publicado: (2019)